Publications by authors named "Asif Alavi"

Claim this Profile
R
Real world analysis of long-term efficacy of isovolemic red cell exchange in sickle cell disease: a single center experience.
Nikhil Vojjala, Rishab Prabhu, Janaka Ss Liyanage, Dipen Kumar Modi, Jay Yang, Asif Alavi

Blood Transfus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease.
Samuel Lessard, Pauline Rimmelé, Hui Ling, Kevin Moran, Benjamin Vieira, Asif Alavi

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Asif Alavi

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission.
Omar Albanyan, Samer Alkassis, Seongho Kim, Andrew Kin, Asif Alavi

Hematol Oncol Stem Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review.
Bayan Al-Share, Hadeel Assad, Judith Abrams, Abhinav Deol, Asif Alavi

J Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.
Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Asif Alavi

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Corey Cutler, Stephanie J Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Asif Alavi

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Asif Alavi

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD.
Vijendra Singh, Hyejeong Jang, Seongho Kim, Lois Ayash, Asif Alavi

Leuk Lymphoma· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
Nadine Abdallah, Seongho Kim, Lois Ayash, Scott Klimecki, Marie Ventimiglia, Asif Alavi

Bone Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma.
Dipenkumar Modi, Jie Chi, Seongho Kim, Lois Ayash, Asif Alavi

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma.
Dipenkumar Modi, Seongho Kim, Malini Surapaneni, Lois Ayash, Asif Alavi

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts.
Harsh Shah, Seongho Kim, Paramveer Singh, Asif Alavi, Voravit Ratanatharathorn

Am J Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome.
Dipenkumar Modi, Seongho Kim, Vijendra Singh, Lois Ayash, Asif Alavi

Leuk Lymphoma· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
Dipenkumar Modi, Jing Christine Ye, Malini Surapaneni, Vijendra Singh, Wei Chen, Asif Alavi

Am J Hematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
Dipenkumar Modi, Malini Surapaneni, Seongho Kim, Lois Ayash, Asif Alavi

Leuk Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Divaya Bhutani, Charles Jaiyeoba, Seongho Kim, Paul Naylor, Joseph P Uberti, Asif Alavi

Bone Marrow Transplant· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
Dipenkumar Modi, Zaid Al-Kadhimi, Wei Chen, Hyejeong Jang, Abhinav Deol, Asif Alavi

Am J Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission.
Rada M Grubovikj, Asif Alavi, Ahrin Koppel, Mary Territo, Gary J Schiller

Cancers (Basel)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways.
Emil Heinze, Grace Chan, Rachel Mory, Raz Khavari, Asif Alavi

Oncol Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis